Case Based Discussion: Surgical and Medical Management of Drug-Resistant Epilepsy EM

---

ONLINECMEMOCConferences & SymposiaComplimentary - No Fee

Wednesday, October 20, 2021, 6:00 PM - Monday, October 31, 2022, 11:00 PM

During the activity, the presenters will review two neurology cases, as well as two surgical epilepsy cases. Each case will be specific to the treatment of adult patients with epilepsy, whose diseases have been resistant to medication. The four cases will provide a review of current medical and surgical practices and will highlight technological advances in monitoring and treating seizures and epilepsy.

Following the case discussion, Drs. Davis and Gelfand will review the qualifications and process for referring patients to a Level 4 Epilepsy Center.

Epilepsy-related disorders can cause recurrent seizures that can occur without warning. Management of drug-resistant epilepsy requires comprehensive, individualized evaluation and advanced facilities. This discussion will highlight a variety of treatments offered at the Penn Epilepsy Center and conclude with a Q&A panel.

1. Discuss the latest information in drug-resistant epilepsy treatment
2. Describe advances in clinical and surgical treatment of epilepsy
3. Identify the gaps in treatment that exist for patients with recurrent attacks when medication fails
4. Recognize the impact of video monitoring in diagnosis and treatment of patients with recurrent seizures that are resistant to medication
5. Determine when to send patients to a Level 4 Epilepsy Center

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

Penn Medicine designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

AMA PRA Category 1 Credits™ (1.50 hours), Non-Physician Attendance / Participation (1.50 hours), ABIM MOC Part 2 (1.50 hours)

Mitigation of Relevant Financial Relationships

Penn Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

No faculty are available for this activity at this time.